In vitro activities of pazufloxacin, a novel injectable quinolone, against bacteria causing infections in obstetric and gynecological patients

Chemotherapy

Volumn 45, Issue 3, 1999, Pages 154-157

  Mikamo, Hiroshige ^a   Sato, Yasumasa ^b   Hayasaki, Yoh ^b   Kawazoe, Kyoko ^b   Tamaya, Teruhiko ^b  

^a GIFU UNIVERSITY   (Japan)

^b NONE

Author keywords

Minimal inhibitory concentrations; Pazufloxacin; T 3762

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; CONTROLLED STUDY; ESCHERICHIA COLI; GARDNERELLA VAGINALIS; GYNECOLOGIC INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA BIVIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS AGALACTIAE;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; BACTERIA, ANAEROBIC; BACTEROIDES FRAGILIS; ESCHERICHIA COLI; FEMALE; FLUOROQUINOLONES; GARDNERELLA VAGINALIS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZINES; PEPTOSTREPTOCOCCUS; PREVOTELLA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS AGALACTIAE;

EID: 0032905263     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007177     Document Type: Article

References (7)

1. Wolfson JS, Hooper DC: The fluoroquinolones: Clinical and laboratory considerations. Clin Microbiol Newslett 1992;14:1-7.
2. Toda Y, Takagi H, Fukuoka Y, Takahata M, Okamoto S, Saikawa I, Narita H: Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4- benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analogues. Chem Pharm Bull 1994;42:2569-2574.
3. Muratani T, Inoue M, Mitsuhashi S: In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother 1992;36:2293-2303.
4. Fukuoka Y, Ikeda Y, Yamashiro Y, Takahata M, Todo T, Narita H: In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrob Agents Chemother 1993;37:384-392.
5. Mikamo H, Kawazoe K, Sato Y, Tamaya T: Therapeutic effects of an injectable new quinolone, pazufloxacin, against polymicrobial infections in the uterine endometritis model. Chemotherapy 1998;44:99-102.
6. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, ed 2. NCCLS Document M7-A2, 1990, vol 10, No 8.
7. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility testing of anaerobic bacteria, ed 2. Approved standard M11-A2. NCCLS Document M11-A2, 1990, vol 10, No 15.